Skip to main content
Advertisement
Advertisement
BTTC
BTTC logo
Black Titan Corporation Ordinary Shares
0.27
USD
Sponsored
+0.01
+2.02%
Nov 18, 09:41 UTC -5
Open

Black Titan Corporation Ordinary Shares (BTTC) Earnings

BTTC Earnings Reports

Positive Surprise Ratio

No Data Available for BTTC

0%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Black Titan Corporation Ordinary Shares earnings per share and revenue

On Aug 12, 2026, BTTC reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Rein Therapeutics, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.10
Actual
-$0.06
Surprise
+41.18%
logo
Instil Bio, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.62
Surprise
-261.09%
logo
Connect Biopharma Holdings Limited Ordinary Shares
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.27
Actual
-$0.26
Surprise
+4.59%
logo
Jasper Therapeutics, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$3.02
Actual
-$13.97
Surprise
-361.93%
logo
Dare Bioscience, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.18
Surprise
+32.13%
logo
GT Biopharma Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$2.54
Actual
-$1.98
Surprise
+22.35%
logo
Lantern Pharma Inc. Common Stock
Report Date
Nov 17, 2026 For Q3 26
Estimate
-$0.35
Actual
-$0.81
Surprise
-126.89%
logo
Pulmatrix, Inc. Common Stock
Report Date
Nov 17, 2026 For Q3 26
Estimate
-
Actual
-$0.34
Surprise
-
logo
HCW Biologics Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$1.37
Actual
-$1.53
Surprise
-11.11%
logo
Aptevo Therapeutics Inc
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$3.78
Actual
-$5.19
Surprise
-36.96%
FAQ
For Q2 2026, Black Titan Corporation Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for --.
Based on -- analysts, Black Titan Corporation Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement